Home » Newsletters » BioWorld Science

BioWorld Science

May 10, 2012

View Archived Issues

GSK patents new transient receptor potential TRPV1 channel antagonists

Novel cyclopropylamines presented by Oryzon Genomics

Purdue Pharma develops novel sodium channel antagonists

Cadila Healthcare discovers novel GPR119 receptor agonists

AC Immune and Belgian KUL design new products for tau-related disorders

Novel anticancer compounds synthesized at Nerviano Medical Sciences

Ongoing ARVO meeting features phase II results on ACU-4429 in AMD

Galderma submits reply to FDA for Pliaglis sNDA

Toll-like receptor antagonist active in autoimmune disease models

New Kyowa Hakko Kirin product demonstrates anticancer activity

Further phase III data reported on SNRI for depression

Seattle Genetics molecule inhibits fucosylation in vitro and in vivo

Aeras and CanSino enter collaboration to advance TB vaccine candidate

ImmunoCellular Therapeutics advances phase II ICT-107 trial

Novavax launches new phase I trial of VLP A/H5N1 flu vaccine candidate

Nuevolution receives milestone payment in collaboration

Evotec and 4-Antibody to collaborate on antibody screening and selection

Achillion kicks off phase I trial of second-generation pan-genotypic hepatitis C drug

FDA committee recommends approval of Pfizer product for RA

DARA BioSciences to advance neuropathic pain candidate

Resverlogix completes dosing in SUSTAIN study

New Xarelto sNDA submitted

Merck KGaA reports interim analysis from Erbitux adjuvant study

Transgene gives update on development of HPV vaccine candidate

Pluristem PLX cells effective in child with aplastic bone marrow

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...